Please use this identifier to cite or link to this item:
Title: No correlation between lymphocyte pharmacodynamics and autoimmune adverse events following alemtuzumab treatment in patients with relapsing-remitting multiple sclerosis
Authors: Wiendl, H.
Brandes, D.
Carraro, M.
Comi, G.
Mao-Draayer, Y.
Izquierdo, G.
Kim, H. -J.
Meuth, S.
Pardo, G.
Sharrack, B.
Tornatore, C.
Ziemssen, T.
Jacobs, Alessia
Chung, L.
Daizadeh, N.
Issue Date: 2018
Source: MULTIPLE SCLEROSIS JOURNAL, 24(2), p. 468-469
Notes: [Wiendl, H.; Meuth, S.] Univ Munster, Munster, Germany. [Brandes, D.] Hope MS Ctr, Knoxville, TN USA. [Carraro, M.] Novant Hlth, Charlotte, NC USA. [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy. [Mao-Draayer, Y.] Univ Michigan, Sch Med, Ann Arbor, MI USA. [Izquierdo, G.] Virgen Macarena Univ Hosp, Seville, Spain. [Kim, H. -J.] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea. [Pardo, G.] Oklahoma Med Res Fdn, OMRF Multiple Sclerosis Ctr Excellence, 825 NE 13th St, Oklahoma City, OK 73104 USA. [Sharrack, B.] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England. [Tornatore, C.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA. [Ziemssen, T.] Carl Gustav Carus Univ Hosp, Ctr Clin Neurosci, Dresden, Germany. [Jacobs, A.; Chung, L.; Daizadeh, N.] Sanofi, Cambridge, MA USA. [Van Wijmeersch, B.] Hasselt Univ, Rehabil & MS Ctr Overpelt, BIOMED, Hasselt, Belgium.
Document URI:
ISSN: 1352-4585
e-ISSN: 1477-0970
ISI #: 000446861401230
Category: M
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
Poster Session 2.pdf
  Restricted Access
Published version82.59 kBAdobe PDFView/Open    Request a copy
Show full item record

Page view(s)

checked on Sep 7, 2022


checked on Sep 7, 2022

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.